Clinical trials
Placebo - Control clinical trials
Below are recruiting placebo - control clinical trials, each written for real people, not researchers. We’re tracking 3,902 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07835633RecruitingPhase 1
Safety study of a single injection of ACC085 in healthy adults
This trial tests a new medication called ACC085 given as a single injection to healthy adults. The goal is to find out how safe it is and how the body processes it.
Wuhan, HubeiAges 18–55 - NCT07834463Recruiting
Herbal extract for menopause symptom relief
This study tests whether a natural plant extract can ease menopausal hot flashes and improve overall menopause-related discomfort. If you're a woman going through natural menopause, you may be able to join.
New Port Richey, FloridaAges 45–60 - NCT07840027RecruitingPhase 1
Vaccine for early Parkinson's disease
This study tests a new investigational vaccine called TRB-001 for people with early Parkinson's disease. It looks at whether the vaccine is safe and whether it can help the immune system fight the disease.
ViennaAges 40–75 - NCT07836452RecruitingPhase 1
Study of a new drug for healthy people and those with Stargardt disease
This study tests a new drug called CITY-RBP4 in healthy volunteers and in people with Stargardt disease (STGD1), a genetic condition that causes vision loss. The goal is to see if the drug is safe and how it affects the body, which may help guide future treatments for Stargardt disease.
Melbourne, VictoriaAges 12–45 - NCT07838740RecruitingPhase 1
Weekly weight-loss medication for healthy adults with obesity
This early-stage trial tests a new once-weekly medication (VK2735) that may help with weight loss. It's for healthy adults with obesity who do not have other significant health problems like diabetes.
Lake Forest, CaliforniaAges 18–60 - NCT07838493Recruiting
Nasal spray oxytocin and vasopressin effects on emotion processing
This study tests whether a nasal spray of oxytocin or vasopressin changes how healthy people pay attention to emotional faces. It may help us understand how these hormones affect social behavior.
Chengdu, SichuangAges 18–30 - NCT07834346RecruitingPhase 3
Clarithromycin to prevent new infections in sepsis after pneumonia
This study tests whether an antibiotic called clarithromycin can help prevent additional infections in people who have sepsis from pneumonia. The goal is to see if it helps you recover faster and avoid complications.
Pátrai, AchaeaAges 18 years+ - NCT07837934RecruitingPhase 2
Colchicine to prevent heart disease in adults with type 2 diabetes
This trial tests whether a daily low-dose of colchicine, a common anti-inflammatory medicine, can help prevent heart attacks and strokes in people with type 2 diabetes who do not yet have heart disease. If it works, it could be a simple addition to your current diabetes care.
Singapore, SingaporeAges 21–80 - NCT03582293RecruitingPhase 3
Tranexamic acid to prevent worsening chronic brain bleed
This Phase 3 study tests whether tranexamic acid (a medicine that helps blood clot) can stop a chronic subdural hematoma from getting worse. It’s for people diagnosed by CT who are being treated without surgery at first.
AmsterdamAges 50 years+ - NCT06464744Recruiting
Can brain stimulation help after spinal cord injury?
This trial tests whether repetitive transcranial magnetic stimulation (rTMS), a non-invasive treatment that uses magnetic pulses to stimulate the brain, can improve movement and function in people with chronic spinal cord injury. It may help if you have some movement left below your injury level.
OsloAges 18–80 - NCT06147635RecruitingPhase 2
Tributyrin for early acute pancreatitis
This trial tests a supplement called tributyrin (related to butyrate) to see if it can help prevent complications from acute pancreatitis when given early after diagnosis. It is for people having their first episode of pancreatitis, not for those with certain causes or weakened immune systems.
Delft, South HollandAges 18 years+ - NCT06264882RecruitingPhase 4
Study on ovarian suppression and body changes
This study looks at how temporarily stopping ovarian function affects weight, body fat, and blood vessel health in premenopausal women. If you qualify, you might help researchers understand the risks and benefits of short-term estrogen suppression.
Aurora, ColoradoAges 20–45 - NCT07826533Recruiting
Intravenous papaverine for term prelabour rupture of membranes
This study tests whether giving papaverine through a vein can help start labour in women whose water has broken but who are not yet having contractions. Papaverine is a medicine that relaxes smooth muscles, which may help the cervix prepare for delivery.
HolonAges Any age - NCT07826689RecruitingPhase 1/Phase 2
Oral pill for relapsing multiple sclerosis
This study tests an experimental oral drug, PRO-1562, in two parts: first in healthy volunteers to check safety, then in people with relapsing multiple sclerosis to see if it can reduce disease activity. It may offer a new, convenient treatment option.
Adelaide, South AustraliaAges 18–65 - NCT06341335RecruitingPhase 3
AK104 and AK109 plus paclitaxel for advanced stomach cancer
This trial tests a combination of two experimental immunotherapies (AK104 and AK109) with a standard chemo drug (paclitaxel) for people with advanced stomach or gastroesophageal junction cancer that has grown after initial treatment. The goal is to see if this new combination can help shrink tumors or slow the cancer better than chemo alone.
BeijingAges 18–75 - NCT07829029RecruitingPhase 4
Nighttime bladder leak treatments in older women
This study looks at whether two different bladder medications can help reduce nighttime bathroom trips and urine leaks in women with urgency incontinence. It aims to find out which treatment works better to improve sleep and quality of life.
San Francisco, CaliforniaAges 60 years+ - NCT05071131Recruiting
Inulin supplement to improve gut health in kidney disease
This trial studies whether taking inulin—a dietary fiber—can improve gut bacteria and the gut barrier in people with end-stage kidney disease on hemodialysis. It may help reduce gut-related problems that can affect overall health in kidney disease.
BerlinAges 18–75 - NCT06472583RecruitingPhase 2
Immunotherapy and radiation before breast cancer surgery
This trial tests giving immunotherapy combined with a precise, high-dose radiation boost before surgery for HER2-negative breast cancer. The goal is to see if this approach can improve outcomes, especially for cancers that are more advanced or have spread to a few other spots in the body.
GliwiceAges 18 years+ - NCT07817875RecruitingPhase 3
Tirzepatide for weight loss in children aged 6 to under 12
This study tests a once-weekly medication called tirzepatide to help children aged 6 to under 12 with obesity lose weight. It compares the medication to a placebo (inactive shot) to see if it safely helps with weight loss in this age group.
Tucson, ArizonaAges 6–11 - NCT07824271RecruitingPhase 1
Testing the safety of ALZ-507 in healthy older adults
This study tests a new oral drug called ALZ-507, which is being developed for Alzheimer's disease. It is an early-phase trial to check the drug's safety and how it is processed in the body, in healthy older adults.
Miami, FloridaAges 50–75 - NCT07822061RecruitingPhase 3
Weight loss study for people with excess weight
This study tests an investigational medicine for weight loss in people with excess weight. It aims to see how effective the medicine is and may help you lose weight and improve health.
Sapporo, HokkaidoAges 18 years+ - NCT07822321RecruitingPhase 3
Brexanolone for severe postpartum depression
This trial tests an investigational medicine to help mothers with severe depression that started late in pregnancy or shortly after childbirth. It aims to improve mood and overall well-being.
Tucson, ArizonaAges 15–45 - NCT07823608RecruitingPhase 3
Monthly study medicine for adults with sleep apnea and overweight who use a breathing machine
This study tests an investigational medicine taken once a month for adults with moderate to severe sleep apnea who are overweight or have obesity and use a CPAP or similar breathing machine. It aims to see if the medicine improves sleep-related breathing.
Cullman, AlabamaAges 18 years+ - NCT07819097RecruitingPhase 3
RSV vaccine study for healthy older adults
This study tests an RSV vaccine to see if it is safe and helps your immune system fight the virus. It's for older adults who are generally healthy, and it may help protect you from severe RSV illness.
Scottsdale, ArizonaAges 60 years+
Hear when a new Placebo - Control trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for placebo - control?
- Yes. Clin2 currently lists 3,902 recruiting placebo - control studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a placebo - control trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a placebo - control trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.